GO:0010838 positive regulation of keratinocyte proliferation: Signaling Mechanisms, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0010838 describes any biological process that increases the rate, frequency, or extent of keratinocyte proliferation, a cornerstone of epidermal homeostasis and wound repair [1, 8].
• Positive regulation of keratinocyte proliferation is driven by growth factors, cytokines, autophagy, and metabolic signals that converge on cell-cycle entry and survival pathways [1, 3, 8].
• Dysregulated keratinocyte proliferation underlies psoriasis, impaired wound healing, and skin carcinogenesis, making this GO term directly relevant to human disease [1, 3, 7].
• Key molecular players include FGF12, MDM2, p53, HMGB1, ERK, and autophagy-related proteins that modulate keratinocyte expansion [1, 2, 3, 8].
• Experimental models for studying this process include keratinocyte-specific knockout, point-mutation, knock-in, and overexpression systems, combined with proliferation assays and transcriptomics [4, 7, 8].
• CRISPR-based screening and bioinformatics can identify novel regulators of keratinocyte proliferation for therapeutic target discovery [1, 7].
Description
The Gene Ontology term GO:0010838, positive regulation of keratinocyte proliferation, defines any process that increases the rate, frequency, or extent of keratinocyte multiplication or reproduction, resulting in expansion of the keratinocyte population [1, 8]. Keratinocytes are the predominant cell type of the epidermis, and their controlled proliferation is essential for skin barrier maintenance, wound re-epithelialization, and hair follicle cycling [4, 8]. Disruption of this balance contributes to hyperproliferative skin diseases such as psoriasis and to impaired healing in chronic wounds [1, 3, 7]. Understanding the molecular mechanisms that positively regulate keratinocyte proliferation is therefore a central goal in dermatological research and regenerative medicine [1, 4, 8]. Recent studies have identified diverse signaling inputs, including growth factor pathways, autophagy, and inflammatory mediators, that converge to promote keratinocyte expansion [1, 2, 3, 8]. This article synthesizes published findings on the mechanisms, key genes, disease relevance, and experimental approaches for studying GO:0010838, providing a research-grade resource for scientists and AI-driven knowledge retrieval.
positive regulation of keratinocyte proliferation At A Glance
| GO ID | GO:0010838 |
|---|---|
| GO term | positive regulation of keratinocyte proliferation |
| Ontology | biological_process |
| Synonym | none |
| Definition | Any process that increases the rate, frequency or extent of keratinocyte proliferation. Keratinocyte proliferation is the multiplication or reproduction of keratinocytes, resulting in the expansion of a cell population. |
| Major function | Promotes expansion of keratinocyte populations during epidermal homeostasis, wound healing, and hair follicle cycling. |
| Related processes | Epidermal development, wound re-epithelialization, inflammatory skin diseases, and skin carcinogenesis. |
| Key regulators | FGF12, MDM2, p53, HMGB1, ERK, autophagy-related proteins, and retinoid signaling components. |
| Disease relevance | Psoriasis, impaired wound healing, and skin cancer. |
What Is GO:0010838?
GO:0010838 is a biological process term that captures any mechanism which enhances the proliferation of keratinocytes. In practical terms, it includes signaling events, transcriptional programs, and metabolic changes that increase the rate, frequency, or extent of keratinocyte division, leading to expansion of the keratinocyte population [1, 8]. This term is distinct from negative regulation (GO:0010839) and from general regulation of keratinocyte proliferation (GO:0010837).
Why Is positive regulation of keratinocyte proliferation Important in Cell Biology?
Positive regulation of keratinocyte proliferation is fundamental to skin biology because it governs the regenerative capacity of the epidermis and the response to injury. Imbalances in this process are directly linked to prevalent human diseases, including psoriasis, chronic non-healing wounds, and skin malignancies [1, 3, 7]. Understanding the positive regulators of keratinocyte proliferation provides mechanistic insights into tissue homeostasis and identifies candidate targets for therapeutic intervention in dermatology and regenerative medicine [1, 4, 8].
• Maintains epidermal homeostasis by balancing keratinocyte production and differentiation [4, 8].
• Drives wound re-epithelialization and skin repair after injury.
• Is hyperactivated in psoriasis, contributing to epidermal hyperplasia and inflammation [1, 3].
• Modulates hair follicle cycling and growth [4, 6].
• Represents a target for anti-psoriatic and pro-healing therapeutics [1, 7].
• Influences skin carcinogenesis through uncontrolled keratinocyte expansion.
• Integrates growth factor, cytokine, and metabolic signals [1, 2, 3].
• Provides a framework for CRISPR-based functional genomics in dermatology [1, 7].
What Happens During positive regulation of keratinocyte proliferation?
Initiation by Growth Factors and Cytokines
In simple terms: Growth factors and cytokines act like keys that start the engine of keratinocyte division.
Positive regulation of keratinocyte proliferation is often initiated by extracellular signals such as fibroblast growth factors (FGFs), which bind to receptors on keratinocytes and trigger intracellular signaling cascades. FGF12, for example, has been shown to positively regulate keratinocyte proliferation by stabilizing MDM2 and inhibiting p53 activity in psoriasis. Other mediators, including HMGB1 secreted by keratinocytes, can amplify inflammatory and proliferative responses.
Intracellular Signaling and Cell Cycle Entry
In simple terms: Inside the cell, a relay of molecular switches tells the cell to divide.
Downstream of receptor activation, pathways such as ERK signaling modulate keratinocyte proliferation, with opposing effects observed in keratinocytes versus fibroblasts. Autophagy also plays a positive role in epidermal proliferation, as inhibition of autophagy reduces keratinocyte expansion. These signaling events converge on cell cycle regulators to promote G1/S transition and DNA synthesis [1, 8].
Autophagy and Metabolic Support
In simple terms: Autophagy is a recycling system that provides energy and building blocks for dividing cells.
Autophagy-based unconventional secretion of HMGB1 by keratinocytes is pivotal in psoriatic skin inflammation and contributes to sustained proliferation. Additionally, autophagy positively regulates epidermal proliferation, suggesting that metabolic recycling supports the biosynthetic demands of dividing keratinocytes.
Inflammatory and Retinoid Modulation
In simple terms: Inflammation and vitamin A derivatives can dial the proliferation rate up or down.
Inflammatory mediators such as IL-1β, regulated by NLRP3 inflammasome and HIF-1α pathways, influence keratinocyte proliferation in the context of hair growth. Synthetic retinoid EC23 regulates epidermal proliferation and hair follicle cycling, demonstrating that retinoid signaling can modulate this process. Albendazole has been shown to negatively regulate keratinocyte proliferation, highlighting the existence of inhibitory mechanisms that counterbalance positive regulation.
Exosome-Mediated Crosstalk
In simple terms: Cells release tiny packages that can tell other cells to grow.
Oral keratinocyte-derived exosomes regulate proliferation of fibroblasts and epithelial cells, indicating that paracrine signaling via exosomes can positively influence keratinocyte and epithelial proliferation. This intercellular communication adds another layer of regulation to GO:0010838.
Key Genes Involved in GO:0010838 positive regulation of keratinocyte proliferation
The following genes and proteins have been experimentally implicated in the positive regulation of keratinocyte proliferation, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| FGF12 | Stabilizes MDM2 and inhibits p53, promoting keratinocyte proliferation | Psoriasis pathogenesis; potential therapeutic target |
| MDM2 | E3 ubiquitin ligase that degrades p53, supporting proliferation | Downstream effector of FGF12 |
| TP53 | Tumor suppressor; its inhibition enhances keratinocyte proliferation | Target of MDM2; mutated in skin cancers |
| HMGB1 | Inflammatory mediator secreted via autophagy; promotes psoriatic inflammation | Biomarker and therapeutic target in psoriasis |
| ERK1/2 (MAPK3/MAPK1) | Signaling kinases with context-dependent effects on proliferation | Modulated by polydeoxyribonucleotide in keratinocytes |
| ATG5 | Autophagy-related protein; supports epidermal proliferation | Autophagy pathway regulator |
| ATG7 | Autophagy-related protein; required for autophagy-mediated proliferation | Autophagy pathway regulator |
| NLRP3 | Inflammasome component; modulates IL-1β and keratinocyte proliferation | Target of vitamin D in hair growth |
| IL1B | Pro-inflammatory cytokine; influences keratinocyte proliferation | Downstream of NLRP3 |
| HIF1A | Hypoxia-inducible factor; regulates IL-1β and proliferation | Target of vitamin D signaling |
| RARB | Retinoic acid receptor; mediates retinoid effects on proliferation | Modulated by synthetic retinoid EC23 |
| RARG | Retinoic acid receptor; involved in epidermal proliferation | Retinoid signaling |
| CDKN1A | Cyclin-dependent kinase inhibitor p21; cell cycle brake | Potential downstream target of proliferative signals |
| CCND1 | Cyclin D1; promotes G1/S transition | Cell cycle regulator in keratinocytes |
| MYC | Transcription factor; drives proliferation | Potential downstream effector |
| EGFR | Growth factor receptor; upstream of ERK and proliferation | Target for skin disease therapy |
| KRT14 | Keratinocyte marker; expressed in proliferating basal cells | Lineage marker for proliferation studies |
| KRT6A | Keratin; induced in hyperproliferative epidermis | Marker of activated keratinocytes |
How Is positive regulation of keratinocyte proliferation Regulated?
Positive regulation of keratinocyte proliferation is controlled by a network of signaling pathways, including growth factor receptor signaling (e.g., FGF12-MDM2-p53 axis), ERK/MAPK cascades, autophagy, and inflammatory mediators such as HMGB1 and IL-1β [1, 2, 3, 6, 8]. Retinoid signaling through retinoic acid receptors also modulates this process. These pathways can be influenced by external stimuli such as synthetic retinoids, polydeoxyribonucleotides, and vitamin D analogs [2, 4, 6]. Negative regulators, such as albendazole, can suppress keratinocyte proliferation, indicating that the process is tightly balanced.
positive regulation of keratinocyte proliferation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FGF12 | Psoriasis | Keratinocyte-specific overexpression or knockout in mouse models |
| HMGB1 | Psoriatic skin inflammation | Autophagy-deficient keratinocyte models |
| NLRP3 | Hair growth disorders | NLRP3 knockout mice treated with vitamin D |
| ATG5 | Impaired wound healing | Keratinocyte-specific Atg5 knockout mice |
| RARB | Epidermal hyperplasia | Retinoid-treated keratinocyte cultures |
Psoriasis
Psoriasis is characterized by hyperproliferation of keratinocytes and chronic inflammation. FGF12 promotes keratinocyte proliferation by stabilizing MDM2 and inhibiting p53, contributing to psoriatic epidermal hyperplasia. Autophagy-based secretion of HMGB1 by keratinocytes further amplifies psoriatic inflammation. Targeting these positive regulators may offer therapeutic benefits.
Impaired Wound Healing
Positive regulation of keratinocyte proliferation is essential for re-epithelialization during wound healing. Autophagy plays a positive role in epidermal proliferation, and its dysregulation can impair wound closure. Understanding the drivers of keratinocyte proliferation can inform strategies to accelerate healing in chronic wounds.
Skin Cancer
Uncontrolled keratinocyte proliferation is a hallmark of skin cancers, including squamous cell carcinoma and basal cell carcinoma. The FGF12-MDM2-p53 axis, which promotes proliferation, may contribute to tumorigenesis when deregulated. Inhibiting positive regulators could be a therapeutic approach.
Hair Growth Disorders
Keratinocyte proliferation in the hair follicle is modulated by vitamin D and retinoid signaling. 1,25-(OH)2D3 promotes hair growth by inhibiting NLRP3/IL-1β and HIF-1α/IL-1β pathways, which in turn affect keratinocyte proliferation. Synthetic retinoid EC23 regulates epidermal proliferation and hair follicle cycling.
From positive regulation of keratinocyte proliferation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does FGF12 promote keratinocyte proliferation in vivo? | Keratinocyte-specific FGF12 overexpression or knockout mouse |
| Is MDM2 required for FGF12-mediated proliferation? | MDM2 point-mutation knock-in or knockout keratinocytes |
| What is the role of autophagy in epidermal proliferation? | ATG5 or ATG7 knockout keratinocytes and mouse models |
| How does HMGB1 secretion affect psoriatic inflammation? | HMGB1 knockout or autophagy-deficient keratinocyte models |
| Can retinoids modulate keratinocyte proliferation? | Retinoid receptor (RARB/RARG) knockout or overexpression models |
| Does NLRP3 inhibition affect hair growth? | NLRP3 knockout mice with vitamin D treatment |
How to Study the positive regulation of keratinocyte proliferation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| EdU/BrdU incorporation | DNA synthesis | Quantifying keratinocyte proliferation in vitro |
| Ki-67 immunostaining | Proliferating cells in tissue | Assessing epidermal hyperplasia in psoriasis models [1, 3] |
| RNA-seq | Global gene expression | Identifying pathways that positively regulate proliferation |
| Co-immunoprecipitation | Protein-protein interactions | Validating FGF12-MDM2 interaction |
| Western blot | Protein expression and phosphorylation | Measuring ERK activity and p53 levels [1, 2] |
| Autophagy flux assays | Autophagic activity | Evaluating autophagy role in proliferation |
| Exosome isolation and treatment | Paracrine signaling | Testing keratinocyte-derived exosome effects |
| CRISPR library screening | Gene function at scale | Discovering novel regulators of keratinocyte proliferation [1, 7] |
Proliferation Assays
Standard methods to measure keratinocyte proliferation include BrdU or EdU incorporation, Ki-67 immunostaining, and MTT assays. These assays quantify DNA synthesis and cell viability, providing direct readouts of positive regulation [1, 7, 8].
Transcriptomics and RNA-seq
RNA sequencing can identify gene expression changes associated with enhanced keratinocyte proliferation, revealing downstream targets of pathways such as FGF12-MDM2-p53. Comparative transcriptomics between proliferating and quiescent keratinocytes can uncover novel regulators.
Protein-Protein Interaction Studies
Co-immunoprecipitation and mass spectrometry can detect interactions such as FGF12-MDM2, which are critical for stabilizing MDM2 and inhibiting p53. These methods help define the molecular mechanism of positive regulation.
In Vivo Models and Imaging
Mouse models with keratinocyte-specific genetic modifications, combined with immunofluorescence for proliferation markers (e.g., Ki-67, KRT14), allow spatial and temporal assessment of keratinocyte proliferation in tissues [4, 6, 8].
How CRISPR Can Be Used to Study GO:0010838 positive regulation of keratinocyte proliferation
Knockout
CRISPR knockout of positive regulators such as FGF12, MDM2, or ATG5 in keratinocytes can confirm their requirement for proliferation. For example, FGF12 knockout reduces keratinocyte proliferation and p53 stabilization. Knockout of autophagy genes impairs epidermal proliferation.
Point Mutation
Point mutations can dissect specific domains or phosphorylation sites. For instance, mutating the MDM2 binding domain of FGF12 or p53 phosphorylation sites can reveal their roles in proliferation. Such models help distinguish between scaffolding and catalytic functions.
Knock-in
Knock-in of tagged versions (e.g., GFP or HA) of FGF12 or MDM2 allows live-cell imaging and interaction studies in keratinocytes. Knock-in of disease-associated mutations can model psoriasis or skin cancer.
Overexpression
Overexpression of FGF12 or HMGB1 in keratinocytes enhances proliferation and inflammation, mimicking psoriatic phenotypes [1, 3]. Overexpression models are useful for gain-of-function studies and drug testing.
How EDITGENE Supports positive regulation of keratinocyte proliferation Research
Researchers studying positive regulation of keratinocyte proliferation-related genes often need to determine whether a candidate gene is causally involved in driving keratinocyte expansion. EDITGENE provides comprehensive CRISPR-based services to generate knockout, point-mutation, knock-in, and overexpression cell models, as well as CRISPR library screening and bioinformatics support, enabling rigorous functional validation of genes implicated in GO:0010838.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of keratinocyte proliferation research.
Frequently Asked Questions About positive regulation of keratinocyte proliferation
What is GO:0010838?
GO:0010838 is the Gene Ontology term for positive regulation of keratinocyte proliferation, defined as any process that increases the rate, frequency, or extent of keratinocyte multiplication or reproduction [1, 8].
What genes are involved in positive regulation of keratinocyte proliferation?
Key genes include FGF12, MDM2, TP53, HMGB1, ATG5, ATG7, NLRP3, IL1B, HIF1A, and retinoid receptors RARB and RARG [1, 2, 3, 4, 6, 8].
How is keratinocyte proliferation regulated?
It is regulated by growth factors, cytokines, autophagy, ERK signaling, and inflammatory mediators that converge on cell cycle entry and survival pathways [1, 2, 3, 8].
What diseases are associated with abnormal keratinocyte proliferation?
Psoriasis, impaired wound healing, skin cancer, and hair growth disorders are associated with dysregulated keratinocyte proliferation [1, 3, 4, 6, 7].
What methods are used to study positive regulation of keratinocyte proliferation?
Common methods include EdU/BrdU incorporation, Ki-67 staining, RNA-seq, co-immunoprecipitation, Western blot, autophagy flux assays, and CRISPR screens [1, 2, 5, 8].
How does FGF12 regulate keratinocyte proliferation?
FGF12 stabilizes MDM2 and inhibits p53 activity, thereby promoting keratinocyte proliferation in psoriasis.
What is the role of autophagy in keratinocyte proliferation?
Autophagy plays a positive role in epidermal proliferation, and autophagy-based HMGB1 secretion contributes to psoriatic inflammation [3, 8].
Can CRISPR be used to study keratinocyte proliferation?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable functional dissection of genes regulating keratinocyte proliferation [1, 7, 8].
What is the connection between vitamin D and keratinocyte proliferation?
1,25-(OH)2D3 promotes hair growth by inhibiting NLRP3/IL-1β and HIF-1α/IL-1β signaling, which modulates keratinocyte proliferation.
How do retinoids affect keratinocyte proliferation?
Synthetic retinoid EC23 regulates epidermal proliferation and hair follicle cycling, indicating that retinoid signaling can modulate this process.
Conclusion
GO:0010838, positive regulation of keratinocyte proliferation, is a critical biological process that governs epidermal homeostasis, wound healing, and hair follicle cycling. Its dysregulation contributes to psoriasis, skin cancer, and impaired wound repair. Key molecular players such as FGF12, MDM2, p53, HMGB1, and autophagy-related proteins have been experimentally linked to this process. CRISPR-based models and functional genomics approaches offer powerful tools to further dissect the mechanisms and identify therapeutic targets. EDITGENE provides end-to-end services to support such research, from knockout and knock-in models to library screening and bioinformatics.
References
- 1. Wang N et al.. 2024. FGF12 Positively Regulates Keratinocyte Proliferation by Stabilizing MDM2 and Inhibiting p53 Activity in Psoriasis.. Adv Sci (Weinh) 11(39):e2400107 PMID: 39234815
- 2. Shin SM et al.. 2023. Polydeoxyribonucleotide exerts opposing effects on ERK activity in human skin keratinocytes and fibroblasts.. Mol Med Rep 28(2) PMID: 37350391
- 3. Wang Z et al.. 2021. Autophagy-based unconventional secretion of HMGB1 by keratinocytes plays a pivotal role in psoriatic skin inflammation.. Autophagy 17(2):529-552 PMID: 32019420
- 4. Määttä A et al.. 2023. Regulation of epidermal proliferation and hair follicle cycling by synthetic photostable retinoid EC23.. J Cosmet Dermatol 22(5):1658-1669 PMID: 36718827
- 5. Sjoqvist S et al.. 2019. Oral keratinocyte-derived exosomes regulate proliferation of fibroblasts and epithelial cells.. Biochem Biophys Res Commun 514(3):706-712 PMID: 31078263
- 6. Zong X et al.. 2024. 1,25-(OH)(2)D(3) promotes hair growth by inhibiting NLRP3/IL-1β and HIF-1α/IL-1β signaling pathways.. J Nutr Biochem 132:109695 PMID: 38936782
- 7. Di Fusco D et al.. 2020. Albendazole negatively regulates keratinocyte proliferation.. Clin Sci (Lond) 134(7):907-920 PMID: 32236445
- 8. Wang J et al.. 2020. Autophagy plays a positive role in induction of epidermal proliferation.. FASEB J 34(8):10657-10667 PMID: 32598088
